Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.
Hu L, Zhang J, Tian M, Kang N, Xu G, Zhi J, Ruan X, Hou X, Zhang W, Yi J, Ma W, Chang L, Tang T, Zheng X, Wei X, Gao M.
Hu L, et al. Among authors: ma w.
Cell Death Dis. 2022 Feb 8;13(2):124. doi: 10.1038/s41419-022-04550-0.
Cell Death Dis. 2022.
PMID: 35136031
Free PMC article.